Thermo Fisher Scientific to Acquire Life Technologies Corporation

16-Apr-2013 - USA

Thermo Fisher Scientific and Life Technologies Corporation have signed a definitive agreement under which Thermo Fisher will acquire Life Technologies for $76.00 in cash per fully diluted common share, or approximately $13.6 billion, plus the assumption of net debt at close ($2.2 billion as of year end 2012).

The transaction, which was approved by both companies’ boards of directors, will create an unrivaled leader in serving research, specialty diagnostics and applied markets. The combination builds on both companies’ technological strengths to accelerate results for life sciences customers working in proteomics, genomics and cell biology.

“We are extremely excited about this transaction because it creates the ultimate partner for our customers and significant value for our shareholders,” said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. “The acquisition of Life Technologies enhances all three elements of our growth strategy: technological innovation, a unique customer value proposition and expansion in emerging markets.

“Our customers in research and applied markets will now be able to achieve even higher levels of innovation and productivity by working with the combined company. We’re especially excited about the new opportunities we will have to leverage our complementary offerings, fueled by a shared commitment to continuous innovation. For our shareholders, we expect the transaction to generate attractive financial returns, as well as significant and immediate accretion to our adjusted EPS.”

Gregory T. Lucier, chairman and chief executive officer of Life Technologies, said, “This transaction brings together two companies intent on accelerating innovation for our customers and achieving greater success in a highly competitive global industry. Further, this combination delivers immediate and significant cash value to our stockholders and represents a successful conclusion to the board’s strategic review to enhance stockholder value and develop an even stronger future for Life Technologies. We look forward to joining forces with the outstanding team at Thermo Fisher, which shares our commitment to customers, employees and the communities we serve.”

Casper added, “We look forward to welcoming our new colleagues from Life Technologies to the Thermo Fisher team. Together, we will be in an even stronger position to fulfill our company’s mission, which is to enable our customers to make the world healthier, cleaner and safer.”

Life provides products and services to customers conducting scientific research and genetic analysis, as well as those in applied markets, such as forensics and food safety testing. With 2012 revenues of $3.8 billion, its comprehensive offering includes a broad range of reagents, consumables, instruments and systems. Life’s  technologies are protected by approximately 5,000 patents and licenses, and it builds on this position through a strong commitment to innovation. Life has an expansive commercial presence and global footprint as well, with more than 10,000 employees serving its customers around the world.

It is expected that Life Technologies’ president and chief operating officer, Mark P. Stevenson, will have a significant leadership role in the combined company. In addition, Thermo Fisher intends to elect a member of the Life Technologies board of directors to the Thermo Fisher board.

Other news from the department business & finance

These products might interest you

SepsiTest™-UMD CE IVD

SepsiTest™-UMD CE IVD by Molzym

Make yourself independent: 16S/18S PCR for pathogen identification

Fast and precise detection of bacteria and fungi in blood/body fluids and tissue

diagnostic kits
SureSTART Vials and Well Plates

SureSTART Vials and Well Plates by Thermo Fisher Scientific

SureSTART autosampler vials for all chromatography applications and budgets

3 performance level: Easily select products suited to your analytical, performance or value needs

consumables
Micro-Dx™ CE IVD

Micro-Dx™ CE IVD by Molzym

Fully automated from sample to PCR analysis

Rapid identification of bacteria and fungi without time-consuming cultivation

DNA extraction kits
Greener Alternative Products

Greener Alternative Products by Merck Life Science

Sustainable laboratory products for environmentally conscious research

Over 2,500 ecological alternatives to reduce your laboratory footprint

consumables
Starlab product guide

Starlab product guide by STARLAB

From pipette tips to centrifuges - laboratory equipment for every need

Discover the Starlab product range now!

Ksep® Consumable Kits

Ksep® Consumable Kits by Sartorius

Ksep® Kits: Cell clarification and harvesting made easy

Automated solutions for higher yield and quality in bioprocessing

consumables
Sartobind® Rapid A

Sartobind® Rapid A by Sartorius

Efficient chromatography with disposable membranes

Increase productivity and reduce costs with fast cycle times

membranes
Consumables & Instruments

Consumables & Instruments by Azenta

Azenta's Sample Consumables and Instruments

Improve sample tracking, ensure sample integrity, and drive process efficiency

Loading...

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance